5-MeO-DMT

Category
alkaloid
Half-Life (t½)
IN: 27m
Formula
C13H18N2O
Molecular Weight
218.29 g/mol
PubChem CID
1832
Aliases
5-MeO-DMT, 5-methoxy-N,N-dimethyltryptamine, O-methyl-bufotenin, toad venom

Pharmacological Mechanism

Very fast, very potent tryptamine psychedelic. A serotonergic agonist with affinity rank 5-HT1A >> 5-HT2A (5-HT1A is the primary high-affinity target, ~300-fold over 5-HT2A). O-demethylated by CYP2D6 to bufotenine and an MAO substrate. Found in Bufo alvarius (Sonoran toad) venom. Risks: extreme intensity, transient hypertension, rare serotonin toxicity when MAOI-combined.

Half-Life & Elimination Curve (IN: 27m)

100%50%25%12.5%0%0h0×t½27m1×t½54m2×t½1.35h3×t½1.8h4×t½2.25h5×t½0×t½ (0h): 100% remaining1×t½ (27m): 50% remaining2×t½ (54m): 25% remaining3×t½ (1.35h): 12.5% remaining4×t½ (1.8h): 6.3% remaining5×t½ (2.25h): 3.1% remaining
Elimination (IN)
  • 0×t½0h100%
  • 1×t½27m50%
  • 2×t½54m25%
  • 3×t½1.35h12.5%
  • 4×t½1.8h6.3%
  • 5×t½2.25h3.1%
Elimination t½27m (IN)
Rate Constant (ke)1.54 h⁻¹
97% Washout (5×t½)2.25h

Dosing Guidelines

Target Organ Systems

Notes

PubChem CID 1832. PK: Rucker 2024 (PMID:38616411) verbatim "the mean terminal elimination half-life was <27 min" (Tmax ~8–10 min) for intranasal BPL-003 5-MeO-DMT benzoate; authored as 0.45 h. 5-HT2A occupancy not authored — 5-HT2A is the weak target (5-HT1A primary) and its Ki is table-only (see AUTHORING_GAPS).

Chemical Structure & Identifiers

References